Osteonecrosis of the jaw - an update (FT11146)

Recommended to all

To update delegates on bisphosphonates, new anti-resorptive bone agents and anti-angiogenic medications, their mechanisms of action and indication for prescription

To be aware of the clinical presentation, signs and symptoms of a medication related osteonecrosis of the jaw (MRONJ)

To be aware of diagnosis and management of patients with an MRONJ and when to refer

To be aware of assessing patient risk of an MRONJ and alternative treatment strategies in the prevention of MRONJ

To be able to manage patients on bisphosphonates and other bone anti-resorptive medications

to be able to ascertain when to refer patients for surgical treatment and when treatment is appropriate in primary dental care

To be able to diagnose and osteonecrosis and prepare the patient for anticipated management upon referral

To be able to prevent any procedures with may induce an osteonecrosis

For delegates to know what the risks for medication-related osteonecrosis of the jaw (MRONJ) are, how to manage the risks, and when to refer to secondary care. Delegates will also gain an understanding of the secondary care management of these patients.